
Chemical Genomics and Proteomics
CRC Press
2. Auflage
Erschienen am 14. Oktober 2016
Buch
Softcover
244 Seiten
978-1-138-19847-0 (ISBN)
Beschreibung
Since the publication of the pioneering first edition of Chemical Genomics and Proteomics more than seven years ago, the area of chemical genomics has rapidly expanded and diversified to numerous novel methods and subdisciplines, such as chemical glycomics and lipidomics. This second edition has been updated to uniquely reflect this interdisciplinary feature as well as the remarkable developments that have occurred. The new edition also covers innovative applications from cell biology to drug discovery to, more recently, clinical diagnostics and medical practice, which utilize the concepts of chemical genomics.
The text provides an overview of the strategies and methodologies of chemical genomics, focusing on emerging technologies and recent applications in the areas of combination chemical genetics, toxicogenomics, drug chemical genomics and proteomics, and orthogonal chemical genetics. It describes the development and application of novel analytical methods used in lipodomics, such as steroidomics. The book also discusses biomarker discovery applications of microarray technologies using DNA, RNA, and protein and glycan arrays. Chapters cover further applications of biomolecular biomarkers for disease diagnosis, in small molecule drug R&D, and during therapeutic use of medicines. These include prognostic, disease specific, response (surrogate), and toxicity biomarkers.
In addition, the text explores the principles of contemporary systems biology and genomics in experimental medicine-a new paradigm that demonstrates a network-oriented view and advanced statistical and informatics data management, opening the way toward personalized medicine. Finally, various in silico chemogenomics approaches are addressed for predicting binding of drug candidates to undesirable targets, which would help in designing better clinical candidates with fewer side effects. This new edition benefits a broad range of readers from industrial and academic researchers in drug discovery, medicinal chemistry, and molecular and cell biology to physicians in clinical diagnostics and students in related fields of study.
The text provides an overview of the strategies and methodologies of chemical genomics, focusing on emerging technologies and recent applications in the areas of combination chemical genetics, toxicogenomics, drug chemical genomics and proteomics, and orthogonal chemical genetics. It describes the development and application of novel analytical methods used in lipodomics, such as steroidomics. The book also discusses biomarker discovery applications of microarray technologies using DNA, RNA, and protein and glycan arrays. Chapters cover further applications of biomolecular biomarkers for disease diagnosis, in small molecule drug R&D, and during therapeutic use of medicines. These include prognostic, disease specific, response (surrogate), and toxicity biomarkers.
In addition, the text explores the principles of contemporary systems biology and genomics in experimental medicine-a new paradigm that demonstrates a network-oriented view and advanced statistical and informatics data management, opening the way toward personalized medicine. Finally, various in silico chemogenomics approaches are addressed for predicting binding of drug candidates to undesirable targets, which would help in designing better clinical candidates with fewer side effects. This new edition benefits a broad range of readers from industrial and academic researchers in drug discovery, medicinal chemistry, and molecular and cell biology to physicians in clinical diagnostics and students in related fields of study.
Rezensionen / Stimmen
Praise for the First Edition"I thoroughly enjoyed this book and have already had to retrieve it from my PhD students who are anxious to read it ...make sure your library has a copy!"
-Journal of Chemical Technology and Biotechnology, Vol. 80, Issue 8, August 2005
"[This book] is the first book dedicated solely to chemical genomics. It presents the most important research and developments in chemical genomics ... The plentiful tables and figures are well-designed and effectively support the content. ... highly recommended for academic and special libraries with relevant programs, and for research scientists in the field."
-E-Streams
Weitere Details
Auflage
2nd edition
Sprache
Englisch
Verlagsort
London
Großbritannien
Verlagsgruppe
Taylor & Francis Ltd
Zielgruppe
Für höhere Schule und Studium
Practitioners and scientists in drug discovery, medicinal chemistry, and molecular/cell biology; physicians in diagnostics and clinical practice; experts in the drug development pipeline; undergraduate and graduate students; and professors teaching courses in medicinal chemistry, pharmacy, and medicine.
Illustrationen
72 s/w Abbildungen, 5 farbige Abbildungen, 46 s/w Photographien bzw. Rasterbilder, 7 s/w Tabellen
7 Tables, black and white; 46 Halftones, black and white; 5 Illustrations, color; 72 Illustrations, black and white
Maße
Höhe: 234 mm
Breite: 156 mm
Gewicht
450 gr
ISBN-13
978-1-138-19847-0 (9781138198470)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Weitere Ausgaben
Andere Ausgaben

Ferenc Darvas | Andras Guttman | Gyoergy Dorman
Chemical Genomics and Proteomics
Buch
01/2013
2. Auflage
CRC Press
235,11 €
Versand in 15-20 Tagen

Ferenc Darvas | Andras Guttman | Gyoergy Dorman
Chemical Genomics and Proteomics
E-Book
01/2013
2. Auflage
CRC Press
104,99 €
Als Download verfügbar

Ferenc Darvas | Andras Guttman | Gyoergy Dorman
Chemical Genomics and Proteomics
E-Book
01/2013
2. Auflage
CRC Press
104,99 €
Als Download verfügbar
Personen
Ferenc Darvas, Andras Guttman, Gyoergy Dorman
Inhalt
Utilizing small molecules in chemical genomics: Toward high-throughput approaches. Development and application of novel analytical methods in lipidomics. From chemical genomics to chemical proteomics: The power of microarray technology. Genomic and proteomic biomarkers in the drug R&D process. Quo vadis biomedical sciences in the omics era: Toward computational biology and medicine. Novel chemogenomic approaches to drug design.